Although CISH molecular method is a fine alternative to FISH for analyzing tissues or TMAs in solid malignancies, there are very limited data on LSCC, in contrast to other malignancies such as breast carcinoma (Sui et al., 2014; Wang et al., 2014; Lundgren et al., 2012). This evidence concerns the gene CISH and breast carcinoma.